The evaluation of ischemic heart disease thallium-201 with comments on radionuclide angiography

Jeffery A. Leppo; James Scheuer; Gerald M. Pohost; Leonard M. Freeman; H. William Strauss

doi:10.1016/S0001-2998(80)80015-8

The evaluation of ischemic heart disease thallium-201 with comments on radionuclide angiography

Jeffery A. Leppo, James Scheuer, Gerald M. Pohost, Leonard M. Freeman, H. William Strauss

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Coronary artery disease causing myocardial ischemia and infarction is the leading cause of death in America. Methods that can be used to diagnose and follow the response to therapy of coronary artery disease or its effect on myocardial ischemia should help control the morbidity and mortality of ischemic heart disease. The use of ECG monitoring is less sensitive and specific for ischemia than thallium (TI) imaging or the use of radionuclide angiography (RNA). In large patient populations, the findings of a positive ECG and TI or RNA study will be highly predictive for the presence of coronary artery disease, while negative test results make the disease unlikely. A combined approach to the patient with possible ischemic heart disease is presented.

Original language	English (US)
Pages (from-to)	115-126
Number of pages	12
Journal	Seminars in nuclear medicine
Volume	10
Issue number	2
DOIs	https://doi.org/10.1016/S0001-2998(80)80015-8
State	Published - Apr 1980
Externally published	Yes

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1016/S0001-2998(80)80015-8

Cite this

@article{2154f94a14f94b2fb90e06dd5e1a027e,

title = "The evaluation of ischemic heart disease thallium-201 with comments on radionuclide angiography",

abstract = "Coronary artery disease causing myocardial ischemia and infarction is the leading cause of death in America. Methods that can be used to diagnose and follow the response to therapy of coronary artery disease or its effect on myocardial ischemia should help control the morbidity and mortality of ischemic heart disease. The use of ECG monitoring is less sensitive and specific for ischemia than thallium (TI) imaging or the use of radionuclide angiography (RNA). In large patient populations, the findings of a positive ECG and TI or RNA study will be highly predictive for the presence of coronary artery disease, while negative test results make the disease unlikely. A combined approach to the patient with possible ischemic heart disease is presented.",

author = "Leppo, {Jeffery A.} and James Scheuer and Pohost, {Gerald M.} and Freeman, {Leonard M.} and {William Strauss}, H.",

note = "Funding Information: From the Division of Nuclear Medicine, Department of Radiology and Cardiac Unit, Department of Medicine, Massachusetts General Hospital, and the Divisions of Nuclear Medicine and Cardiology, Montefiore Hospital and Medical Center, Bronx, New York. Supported in part by NIH Training Grant HL-07416-02. Address reprint requests to H. William Strauss, M.D., Division of Nuclear Medicine, Massachusetts General Hospital, Fruit Street, Boston, Mass. 02114. ~) 1980 by Grune & Stratton, Inc. 0001-2998/80/1002-0001502.00/0",

year = "1980",

month = apr,

doi = "10.1016/S0001-2998(80)80015-8",

language = "English (US)",

volume = "10",

pages = "115--126",

journal = "Seminars in Nuclear Medicine",

issn = "0001-2998",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - The evaluation of ischemic heart disease thallium-201 with comments on radionuclide angiography

AU - Leppo, Jeffery A.

AU - Scheuer, James

AU - Pohost, Gerald M.

AU - Freeman, Leonard M.

AU - William Strauss, H.

N1 - Funding Information: From the Division of Nuclear Medicine, Department of Radiology and Cardiac Unit, Department of Medicine, Massachusetts General Hospital, and the Divisions of Nuclear Medicine and Cardiology, Montefiore Hospital and Medical Center, Bronx, New York. Supported in part by NIH Training Grant HL-07416-02. Address reprint requests to H. William Strauss, M.D., Division of Nuclear Medicine, Massachusetts General Hospital, Fruit Street, Boston, Mass. 02114. ~) 1980 by Grune & Stratton, Inc. 0001-2998/80/1002-0001502.00/0

PY - 1980/4

Y1 - 1980/4

N2 - Coronary artery disease causing myocardial ischemia and infarction is the leading cause of death in America. Methods that can be used to diagnose and follow the response to therapy of coronary artery disease or its effect on myocardial ischemia should help control the morbidity and mortality of ischemic heart disease. The use of ECG monitoring is less sensitive and specific for ischemia than thallium (TI) imaging or the use of radionuclide angiography (RNA). In large patient populations, the findings of a positive ECG and TI or RNA study will be highly predictive for the presence of coronary artery disease, while negative test results make the disease unlikely. A combined approach to the patient with possible ischemic heart disease is presented.

AB - Coronary artery disease causing myocardial ischemia and infarction is the leading cause of death in America. Methods that can be used to diagnose and follow the response to therapy of coronary artery disease or its effect on myocardial ischemia should help control the morbidity and mortality of ischemic heart disease. The use of ECG monitoring is less sensitive and specific for ischemia than thallium (TI) imaging or the use of radionuclide angiography (RNA). In large patient populations, the findings of a positive ECG and TI or RNA study will be highly predictive for the presence of coronary artery disease, while negative test results make the disease unlikely. A combined approach to the patient with possible ischemic heart disease is presented.

UR - http://www.scopus.com/inward/record.url?scp=0018853149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018853149&partnerID=8YFLogxK

U2 - 10.1016/S0001-2998(80)80015-8

DO - 10.1016/S0001-2998(80)80015-8

M3 - Article

C2 - 6994233

AN - SCOPUS:0018853149

SN - 0001-2998

VL - 10

SP - 115

EP - 126

JO - Seminars in Nuclear Medicine

JF - Seminars in Nuclear Medicine

IS - 2

ER -

The evaluation of ischemic heart disease thallium-201 with comments on radionuclide angiography

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this